The Cosmeceutical Properties of Compounds Derived from Marine Algae 213
Klein, T. and R. Bischoff. 2011. Physiology and pathophysiology of matrix metalloproteases. Amino Acids 41: 271–290.
Ko, S.C., S.H. Cha, S.J. Heo, S.H. Lee, S.M. Kang and Y.J. Jeon. 2011. Protective effect of Ecklonia cava on UVB-induced
oxidative stress: in vitro and in vivo zebrafish model. J. Appl. Phycol. 23: 697–708.
Koivikko, R., J. Loponen, T. Honkanen and V. Jormalainen. 2005. Contents of soluble, cell-wall-bound and exuded phlorotannins
in the brown alga Fucus vesiculosus, with implications on their ecological functions. J. Chem. Ecol. 31: 195–212.
Koivikko, R., J. Loponen, K. Pihlaja and V. Jormalainen. 2007. High-performance liquid chromatographic analysis of
phlorotannins from the brown alga Fucus vesiculosus. Phytochem. Anal. 18: 326–332.
Kreil, G. 1995. Hyaluronidases—a group of neglected enzymes. Protein Sci. 4: 1666–1669.
Kylin, H. 1913. Biochemistry of sea algae. Z. Physiol. Chem. 83: 171–197.
Lapcik, L., Jr., L. Lapcik, S. De Smedt, J. Demeester and P. Chabrecek. 1998. Hyaluronan: preparation, structure, properties,
and applications. Chem. Rev. 98: 2663–2684.
Lavker, R. 1979. Structural alterations in exposed and unexposed aged skin. J. Invest. Dermatol. 73: 59–66.
Lee, S., Y. Lee, S. Jung, S. Kang and K. Shin. 2003. Anti-oxidant activities of fucosterol from the marine algae Pelvetia
siliquosa. Arch. Pharm. Res. 26: 719–722.
Li, B., F. Lu, X. Wei and R. Zhao. 2008. Fucoidan: structure and bioactivity. Molecules 13: 1671–1695.
Li, H.B. and F. Chen. 2001. Preparative isolation and purification of astaxanthin from the green microalga Chlorococcum
sp. by high-speed counter-current chromatography. pp. 127–134. F. Chen and Y. Jiang (eds.). In: Algae and Their
Biotechnological Potential: Proceedings of the 4th Asia-Pacific Conference on Algal Biotechnology, 3–6 July 2000 in
Hong Kong. Springer Netherlands, Dordrecht.
Li, X.C., X. Fan, L.J. Han, X.J. Yan and Q.X. Lou. 2002. Fatty acids of common marine macrophytes from the Yellow and
Bohai Seas. Oceanol. Limnol. Sin. 33: 215–223.
Li, Y., Z.J. Qian, B. Ryu, S.H. Lee, M.M. Kim and S.K. Kim. 2009. Chemical components and its antioxidant properties
in vitro: An edible marine brown alga, Ecklonia cava. Bioorg. Med. Chem. 17: 1963–1973.
Lim, S.N., P.C.K. Cheung, V.E.C. Ooi and P.O. Ang. 2002. Evaluation of antioxidative activity of extracts from a brown
seaweed, Sargassum siliquastrum. J. Agric. Food Chem. 50: 3862–3866.
Mansour, M.P., J.K. Volkman, D.G. Holdsworth, A.E. Jackson and S.I. Blackburn. 1999. Very-long-chain (C28) highly
unsaturated fatty acids in marine dinoflagellates. Phytochemistry 50: 541–548.
Marcussi, S., C.D. Sant‘Ana, C.Z. Oliveira, A.Q. Rueda, D.L. Menaldo, R.O. Beleboni, R.G. Stabeli, J.R. Giglio, M.R. Fontes
and A.M. Soares. 2007. Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential. Curr.
Top. Med. Chem. 7: 743–756.
Matsukawa, R., Z. Dubinsky, E. Kishimoto, K. Masaki, Y. Masuda, T. Takeuchi, A.M. Chihar, Y. Yamamoto, E. Niki and
I. Karube. 1997. A comparison of screening methods for antioxidant activity in seaweeds. J. Appl. Phycol. 9: 29–35.
McCaffrey, T.A., D.J. Falcone, D. Vicente, B. Du, S. Consigli and W. Borth. 1994. Protection of transforming growth factor-β1
activity by heparin and fucoidan. J. Cell Physiol. 159: 51–59.
Meyer, K. and J.W. Palmer. 1934. The polysaccharide of the vitreous humor. J. Biol. Chem. 107: 629–634.
Mizutani, S., S. Deguchi, E. Kobayashi, E. Nishiyama, H. Sagawa and I. Kato. 2010. Fucoidan-containing cosmetics. US
7678368 B2.
Moon, H.J., S.R. Lee, S.N. Shim, S.H. Jeong, V.A. Stonik, V.A. Rasskazov, T. Zvyagintseva and Y.H. Lee. 2008. Fucoidan
inhibits UVB-induced MMP-1 expression in human skin fibroblasts. Biol. Pharm. Bull. 31: 284–289.
Nettleton, J.A. 1995. Omega-3 Fatty Acids and Health. Chapman & Hall, New York.
Nomura, T., M. Kikuchi, A. Kubodera and Y. Kawakami. 1997. Proton-donative antioxidant activity of fucoxanthin with
1,1-diphenyl-2-picrylhydrazyl (DPPH). Biochem. Mol. Biol. Int. 42: 361–370.
O’Leary, R., M. Rerek and E.J. Wood. 2004. Fucoidan modulates the effect of transforming growth factor (TGF)-β 1 on fibroblast
proliferation and wound repopulation in in vitro models of dermal wound repair. Biol. Pharm. Bull. 27: 266–270.
Oren, A. and N. Gunde-Cimerman. 2007. Mycosporines and mycosporine-like amino acids: UV protectants or multipurpose
secondary metabolites? FEMS Microbiol. Lett. 269: 1–10.
Paduch, R., M. Kandefer-Szersze, M. Trytek and J. Fiedurek. 2007. Terpenes: substances useful in human healthcare. Arch.
Immunol. Ther. Exp. (Warsz.). 55: 315–327.
Patankar, M.S., S. Oehninger and T. Barnett. 1993. A revised structure for fucoidan may explain some of its biological activities.
J. Biol. Chem. 268: 21770–21776.
Patel, M.K., B. Mulloy, K.L. Gallagher, L. O‘Brien and A.D. Hughes. 2002. The antimitogenic action of the sulphated
polysaccharide fucoidan differs from heparin in human vascular smooth muscle cells. Thromb. Haemost. 87: 149–154.
Patil, V., T. Källqvist, E. Olsen, G. Vogt and H.R. Gislerød. 2007. Fatty acid composition of 12 microalgae for possible use
in aquaculture feed. Aquacult. Int. 15: 1–9.
Pavia, H. and E. Brock. 2000. Extrinsic factors influencing phlorotannin production in the brown alga Ascophyllum nodosum.
Mar. Ecol. Prog. Ser. 193: 285–294.
Percival, E.G.V. and A.G. Ross. 1950. Fucoidin. Part I. The isolation and purification of fucoidin from brown seaweeds.
J. Chem. Soc. 717–720.
Pereira, H., L. Barreira, F. Figueiredo, L. Custódio, C. Vizetto-Duarte, C. Polo, E. Rešek, A. Engelen and J. Varela. 2012.
Polyunsaturated fatty acids of marine macroalgae: Potential for nutritional and pharmaceutical applications. Mar. Drugs.
10: 1920–1935.
Précédent

- 222/342

Suivant